4//SEC Filing
China Biologic Products, Inc. 4
Accession 0001144204-15-055246
CIK 0001369868operating
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:11 PM ET
Size
17.3 KB
Accession
0001144204-15-055246
Insider Transaction Report
Form 4
Yin Ming
Senior Vice President
Transactions
- Exercise/Conversion
Common stock
2015-09-14$9.85/sh+1,414$13,928→ 20,841 total - Sale
Common stock
2015-09-14$97.14/sh−7,374$716,310→ 13,467 total - Exercise/Conversion
Stock Option (right to buy)
2015-09-14−1,414→ 58,586 totalExercise: $9.85From: 2013-09-01Exp: 2022-08-31→ Common stock (1,414 underlying) - Exercise/Conversion
Common stock
2015-09-15$9.85/sh+13,134$129,370→ 26,601 total - Sale
Common stock
2015-09-15$94.65/sh−13,134$1,243,133→ 13,467 total - Exercise/Conversion
Stock Option (right to buy)
2015-09-15−13,134→ 45,452 totalExercise: $9.85From: 2013-09-01Exp: 2022-08-31→ Common stock (13,134 underlying)
Footnotes (8)
- [F1]Represents 1,414 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase 1,414 shares of the Issuer's common stock. See Footnote 6 below for further details on the relevant stock options.
- [F2]Represents 7,374 shares of common stock (the "September 14 Sold Common Stock") sold on the open market at a weighted average price of $97.14 per share on September 14, 2015. The September 14 Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase 1,414 shares of the Issuer's common stock and vesting of 5,960 restricted stocks.
- [F3]Represents 13,134 shares of common stock (the "September 15 Sold Common Stock") sold on the open market at a weighted average price of $94.65 per share on September 15, 2015. The September 15 Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $93.70 to $100.50, inclusive. The Reporting Person undertakes to provide to any security holders of China Biologic Products, Inc. (the "Issuer") or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 4 and Footnote 5 to this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $94.20 to $95.75, inclusive.
- [F6]Represents previously reported stock options to purchase 1,414 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
- [F7]Represents previously reported stock options to purchase 13,134 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
- [F8]Includes the balance of the previously reported stock options to purchase 60,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated July 11, 2010 and August 31, 2012, respectively.
Documents
Issuer
China Biologic Products, Inc.
CIK 0001369868
Entity typeoperating
Related Parties
1- filerCIK 0001369868
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:11 PM ET
- Size
- 17.3 KB